Saturday, 3 October 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 12, 2025

Zacks Industry Outlook Highlights General Motors, Polaris and Blue Bird

View original at finance.yahoo.com
Zacks Industry Outlook Highlights General Motors, Polaris and Blue Bird For Immediate Release Chicago, IL – December 12, 2025 – Today, Zacks Equity Research discusses General Motors Co…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • U.S. auto sales in 2025 will climb to 16.1-16.2 million units, up from 15.98 million in 2024

    80% confidence
  • Someone paying $2,000 in annual interest on auto loan could save roughly $400 each year or about $2,000 across a five-year loan from the proposed tax deduction

    80% confidence
  • Blue Bird expects 2026 to mirror the record results delivered in 2025 and anticipates continued profitable growth in the years ahead as it works toward reaching approximately $2 billion in revenues and an adjusted EBITDA margin exceeding 16%

    80% confidence
  • Chinese automakers boosted their collective share of Europe's total vehicle sales to around 5.1% in the first half of 2025, nearly double their share from a year earlier

    80% confidence
  • The Zacks Domestic Auto industry is set for renewed momentum as affordable EVs and proposed tax incentives encourage buyers despite economic uncertainty and rising tariffs

    80% confidence
  • Polaris expects adjusted sales in the range of $6.9 billion to $7.1 billion for 2025

    80% confidence
  • More budget-friendly EVs are expected to expand adoption, while tariffs may limit foreign rivals, supporting domestic manufacturers

    80% confidence
  • Blue Bird expects fiscal 2026 revenues of $1.5 billion and adjusted EBITDA of $220 million

    80% confidence
  • In China, domestic EV companies have tightened their hold on the market, with their share jumping from 65% in the first half of 2020 to nearly 90% in the first half of 2025

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com